| Literature DB >> 34464545 |
Francesco Frasca1, Tommaso Piticchio1, Rosario Le Moli1, Roberta Malaguarnera2, Alfredo Campennì3, Salvatore Cannavò4,5, Rosaria Maddalena Ruggeri4,6.
Abstract
INTRODUCTION: Hypophysitis is an inflammation of the pituitary gland and a rare case of hypopituitarism. Despite the expanding spectrum of histological variants and causative agents, its pathogenesis is far to be fully understood. The present review is focused on recent evidence concerning the pathogenesis of autoimmune hypophysitis by searching through online databases like MEDLINE and Scopus up to May 2021. AREAS COVERED: Hypophysitis frequently develops in the context of a strong autoimmune background, including a wide spectrum of subtypes ranging from the commonest form of lymphocytic hypophysitis to the newly described and less common IgG4-, anti-PIT-1, and ICI-induced forms. A peculiar combination of genetic predisposition, pituitary damage and immunological setting represents the pathogenetic basis of autoimmune hypophysitis, which is characterized by diffuse infiltration of the gland by lymphocytes and variable degrees of fibrosis followed by pituitary cell destruction. Anti-pituitary antibodies (APA) have been described in sera from patients suffering from autoimmune hypophysitis, though their pathophysiological significance remains largely unknown and their diagnostic value limited. EXPERT OPINION: In recent years hypophysitis has gained interest due to the increased number of new diagnoses and the recognition of novel subtypes. Further studies could lead to improvements in biochemical/immunological diagnosis and targeted treatments.Entities:
Keywords: Autoimmunity; anti-pit-1 hypophysitis-igg4-related hypophysitis; ctla-4; hypothalamitis; immune checkpoint inhibitors; lymphocytic hypophysitis; pituitary
Mesh:
Substances:
Year: 2021 PMID: 34464545 DOI: 10.1080/1744666X.2021.1974297
Source DB: PubMed Journal: Expert Rev Clin Immunol ISSN: 1744-666X Impact factor: 4.473